Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA panel to review renal denervation data | Shared decision-making | PE-backed cardiology group inks another deal
Friday, June 23, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA panel to review renal denervation system PMA submissions

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

READ MORE >
The ReCor (left) and Medtronic Symplicity Spyral renal denervation systems.
Share on Twitter Share on Facebook Share on Linkedin

FDA panel to review renal denervation system PMA submissions

Share on Twitter Share on Facebook Share on Linkedin
The ReCor (left) and Medtronic Symplicity Spyral renal denervation systems.
The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.
READ MORE >

How to encourage shared decision-making when treating aortic stenosis

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

How to encourage shared decision-making when treating aortic stenosis

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 
READ MORE >

Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 

READ MORE >
business news announcement
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Share on Twitter Share on Facebook Share on Linkedin
business news announcement
Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 
READ MORE >

Featured Articles

Top 20 children’s hospitals for cardiology and heart surgery

Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Top 20 children’s hospitals for cardiology and heart surgery

Share on Twitter Share on Facebook Share on Linkedin
Did your facility make the cut? For its 2023-2024 list, U.S. News and World Report evaluated data from 119 hospitals and surveyed thousands of pediatric specialists.
READ MORE >

AI technologies to be featured heavily at ASE 2023

Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland. 

READ MORE >
Artificial intelligence automated measurements on an echocardiogram on the Siemens SyngoDynamics cardiovascular imaging and information solution. AI is helping speed workflows and complete tedious tasks faster and more accurately that humans, allowing sonographers and cardiologists to be more efficient. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

AI technologies to be featured heavily at ASE 2023

Share on Twitter Share on Facebook Share on Linkedin
Artificial intelligence automated measurements on an echocardiogram on the Siemens SyngoDynamics cardiovascular imaging and information solution. AI is helping speed workflows and complete tedious tasks faster and more accurately that humans, allowing sonographers and cardiologists to be more efficient. Photo by Dave Fornell
Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland. 
READ MORE >

FDA grants breakthrough designation for new AI model to detect cardiac amyloidosis in ECG results

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

FDA grants breakthrough designation for new AI model to detect cardiac amyloidosis in ECG results

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.
READ MORE >

In Case You Missed It

Cardiologists perform world’s first TAVR with new ultra-low profile valve

The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

READ MORE >
Valve Medical's Xemed TAVR valve. Xemed TAVR System was developed by Valve Medical, a wholly owned subsidiary of Medinol focused on treating structural heart disease. It features a modular two-piece design and can be implanted using a standard 12 French sheath.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists perform world’s first TAVR with new ultra-low profile valve

Share on Twitter Share on Facebook Share on Linkedin
Valve Medical's Xemed TAVR valve. Xemed TAVR System was developed by Valve Medical, a wholly owned subsidiary of Medinol focused on treating structural heart disease. It features a modular two-piece design and can be implanted using a standard 12 French sheath.
The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.
READ MORE >

Cardiologist accused of date rape by 15 women could face life in prison, judge says

The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.

READ MORE >
Judge bangs gavel
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist accused of date rape by 15 women could face life in prison, judge says

Share on Twitter Share on Facebook Share on Linkedin
Judge bangs gavel
The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.
READ MORE >

In Other News

Latest version of ChatGPT has potential as a clinical decision support tool

Large language models could have feasibility in the future as clinical support tools that triage patients for imaging services—with additional updates and more training, of course.

READ MORE >
ChatGPT large language models radiology health care
Share on Twitter Share on Facebook Share on Linkedin

Latest version of ChatGPT has potential as a clinical decision support tool

Share on Twitter Share on Facebook Share on Linkedin
ChatGPT large language models radiology health care
Large language models could have feasibility in the future as clinical support tools that triage patients for imaging services—with additional updates and more training, of course.
READ MORE >

Radiologist developing $250M medical campus that includes spot for his imaging group

John Tentinger, MD, said he has been working on the deal for about a decade, purchasing the 25-acre piece of land for $5.5M. 

READ MORE >
Shovel
Share on Twitter Share on Facebook Share on Linkedin

Radiologist developing $250M medical campus that includes spot for his imaging group

Share on Twitter Share on Facebook Share on Linkedin
Shovel
John Tentinger, MD, said he has been working on the deal for about a decade, purchasing the 25-acre piece of land for $5.5M. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup